Navigation Links
Motion Filed to Consolidate Yasmin/YAZ Litigation in Toledo, Ohio
Date:7/24/2009

LANCASTER, Pa., July 24 /PRNewswire-USNewswire/ -- Three leading law firms representing 23 of the 32 filed cases around the country have filed a joint motion asking that the Yasmin/YAZ product liability litigation be consolidated and transferred to Chief Judge James G. Carr of the United States District Court for the Northern District of Ohio. The motion was filed today, July 24, 2009, before the Judicial Panel on Multidistrict Litigation in Washington, D.C.

The three law firms represent Plaintiffs from across the country who have suffered injuries, including deep vein thrombosis, pulmonary embolism, heart attack, stroke, kidney failure, seizures, gall bladder injuries, and death after using the birth control pills Yasmin/YAZ and Ocella. The three firms and their lead lawyers handling this litigation are Dianne Nast and Daniel Gallucci of RodaNast, Lancaster, Pennsylvania; Janet Abaray and Michael Burg of Burg Simpson Eldredge Hersh & Jardine, Cincinnati, Ohio and Englewood, Colorado; and David Zoll, Michelle Kranz and Pamela Borgess, Zoll Kranz & Borgess, Toledo, Ohio.

The Defendants in the cases are Bayer Pharmaceuticals Corporation and other Bayer related companies. The FDA issued warning letters to Berlex Laboratories, the predecessor manufacturer to Bayer, in 2003, ordering the Defendants to immediately discontinue a television advertisement that promoted Yasmin's fourth generatio progestin, drospirenone, by stating, "Ask about Yasmin, and the difference a little chemistry can make." The FDA objected and stated "FDA is not aware of substantial evidence or clinical experience demonstrating that Yasmin is superior to other COC's [combination oral contraceptives] or that the drospirenone in Yasmin is clinically beneficial. On the contrary, FDA is aware of the added clinical risks associated with drospirenone."

The FDA issued a second warning letter to Bayer on October 3, 2008, for another advertisement, this time concerning YAZ. The FDA determined that the advertisement was misleading because it failed to disclose that "YAZ has additional risks because it contains the progestin, drospirenone . . ."

Copies of the papers and other information are available as follows:

Janet G. Abaray (513) 852-5600 jabaray@burgsimpson.com

Daniel N. Gallucci (717) 892-3000 dgallucci@rodanast.com

David W. Zoll (419) 841-9623 david@toledolaw.com


'/>"/>
SOURCE RodaNast, P.C.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. HealthFitness Helps Herbalife Engage Employees in Wellness Promotion Program Through Strategic Use of Incentives
2. Avidas(TM) Pharmaceuticals and LaRon(TM) Pharma Inc. Announce Co-Promotion Agreement
3. New Survey Highlights Emotional, Financial Toll Multi-Generational Tobacco Use Takes on Parents Sandwiched In Between
4. Savoring Happy Moments Helps Build Emotional Strength
5. Motion analysis helps soccer players get their kicks
6. CyberGlove Systems Hosts Worldwide Contest for New Motion Capture Technology Applications
7. NetMotion Wireless Enhances Mobile Productivity and Security at Wichita Clinic
8. Lifeclinic Supports Healthy Workforce and Health Promotion First Acts
9. Lifeclinic Supports Healthy Workforce and Health Promotion First Acts
10. Delaware Chancery Court Grants Galil Medical Ltd.s Motion for Expedited Proceeding in Suit Against Endocare
11. Naps with rapid eye movement sleep increase receptiveness to positive emotion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... The American Board of Family Medicine's (ABFM) Board of Directors has selected Warren ... James C. Puffer upon his retirement. Dr. Newton will serve in the position of ... end of 2018. Upon assuming the role of President and CEO on January 1, ...
(Date:10/13/2017)... N.Y (PRWEB) , ... October 13, 2017 , ... Lori ... became a member of ElderCounsel, a national organization of elder law and special needs ... changing laws and rules. It also provides a forum to network with elder law ...
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in agile ... a contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise ... use of Agile methodologies in a consistent and high value manner across CMS ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... Sept. 25, 2017   Montrium , an ... solutions, today—from the IQPC Trial Master Files & ... NL)—announced that EastHORN Clinical Services has selected ... and TMF management. EastHORN, a leading European contract ... to increase transparency to enable greater collaboration with ...
(Date:9/22/2017)... -- AVACEN Medical (AVACEN) announced that its CE-Marked AVACEN ... with the widespread pain associated with fibromyalgia in the ... Essex, England commented, "I had difficulty ... sleep at all, tremendous pain, with every movement sending ... AVACEN 100] enough, how this has and is helping ...
(Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
Breaking Medicine Technology: